Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
253.94
-5.75 (-2.21%)
Oct 29, 2025, 11:40 AM EDT - Market open
Labcorp Holdings Market Cap
Labcorp Holdings has a market cap or net worth of $21.08 billion as of October 29, 2025. Its market cap has increased by 16.01% in one year.
Market Cap
21.08B
Enterprise Value
27.11B
1-Year Change
16.01%
Ranking
Category
Stock Price
$253.94
Market Cap Chart
Since December 1, 1998, Labcorp Holdings's market cap has increased from $164.50M to $21.08B, an increase of 12,712.78%. That is a compound annual growth rate of 19.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 21.58B | 12.51% |
| Dec 31, 2024 | 19.18B | -0.60% |
| Dec 29, 2023 | 19.30B | -7.51% |
| Dec 30, 2022 | 20.86B | -30.62% |
| Dec 31, 2021 | 30.07B | 51.67% |
| Dec 31, 2020 | 19.83B | 20.69% |
| Dec 31, 2019 | 16.43B | 28.84% |
| Dec 31, 2018 | 12.75B | -21.48% |
| Dec 29, 2017 | 16.24B | 22.80% |
| Dec 30, 2016 | 13.22B | 5.68% |
| Dec 31, 2015 | 12.51B | 37.23% |
| Dec 31, 2014 | 9.12B | 14.17% |
| Dec 31, 2013 | 7.99B | -3.87% |
| Dec 31, 2012 | 8.31B | -2.50% |
| Dec 30, 2011 | 8.52B | -4.72% |
| Dec 31, 2010 | 8.94B | 12.50% |
| Dec 31, 2009 | 7.95B | 14.26% |
| Dec 31, 2008 | 6.96B | -20.05% |
| Dec 31, 2007 | 8.70B | -5.56% |
| Dec 29, 2006 | 9.21B | 28.71% |
| Dec 30, 2005 | 7.16B | 3.86% |
| Dec 31, 2004 | 6.89B | 30.34% |
| Dec 31, 2003 | 5.29B | 53.92% |
| Dec 31, 2002 | 3.44B | -39.59% |
| Dec 31, 2001 | 5.69B | -7.07% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |